CARBOXY THERAPY

Carboxytherapy means the use of CO2 for therapeutic purposes. This method was used for the first time in France in 1932 for the treatment of peripheral arterial diseases.

 

Co2 is an odourless and colourless carbon dioxide gas. The subcutaneous administration of CO2 absolutely does not affect breathing and does not cause any risk of embolisms, indeed, the diffusibility of this gas is up to 30 times higher than that of oxygen.

 

Optical probe videocapillaroscopy and Doppler laser flowmetry are two methods of microangiological investigation that have shown respectively that the CO2 action subcutaneously is expressed through a mechanism of vasodilation and an increase in arteriolar sphygmicity with a consequent increase in flow velocity at the level of the microcirculation.

 

The mechanism of action consists, first of all, in a direct stimulation of the arteriolar smooth muscle cells (acidosis) and a sympathetic-mimetic action with a consequent increase in the flow rate and opening of the blocking devices at the level of the capillaries, and secondly in a reduction of the affinity of hemoglobin for O2 with increased tissue oxygenation and lipolysis.

 

  • For this reason, in the forms of so-called cellulitis in which stasis microangiopathy prevails, the subcutaneous administration of CO2 represents a therapy of choice: compactness and elasticity of the skin visibly improves (also demonstrated by elastometric investigation), reduction of skin thickness and superficial depressions (dimpling).
  • The biopsies of patients subjected to CO2 infiltration in the hypodermis at the level of localised adiposity, permitted a histological analyse of the treated tissues and thus verified: “numerous fractures of the adipocyte cell membranes with the presence of lipid material in the interstitium and absence of alterations of the deep dermal and main vascular structures”. This effect translates into a reduction in centimetres of localised adiposity in the abdomen, hips, thighs, knees, buttocks, etc. … Patients undergo one or two weekly sessions for cycles of 10 – 20 sessions and the results are visible from the first sessions.
  • The occasional observation of an increase in elasticity and tone of the skin of the lower limbs, proven by elastometry and histological examination, led us to use carboxytherapy in different body regions, characterised by signs of skin aging: face, neck, décolleté, arms, etc…. The increase in dermal thickness and therefore the fibroblastic stimulation induced by carbon dioxide, explains the fact that the treatment of so-called stretch marks and areas of skin laxity such as the sub-chin region, jaw profile, neck, décolleté, breasts, arms, abdomen, inner thighs and even the eyelids (which until now have been considered a region to be treated only surgically) represent a main indication in the use of this therapy, with results often visible within the first 3-4 treatment sessions.

CARBOXY THERAPY

Carboxytherapy means the use of CO2 for therapeutic purposes. This method was used for the first time in France in 1932 for the treatment of peripheral arterial diseases.

 

Co2 is an odourless and colourless carbon dioxide gas. The subcutaneous administration of CO2 absolutely does not affect breathing and does not cause any risk of embolisms, indeed, the diffusibility of this gas is up to 30 times higher than that of oxygen.

 

Optical probe videocapillaroscopy and Doppler laser flowmetry are two methods of microangiological investigation that have shown respectively that the CO2 action subcutaneously is expressed through a mechanism of vasodilation and an increase in arteriolar sphygmicity with a consequent increase in flow velocity at the level of the microcirculation.

 

The mechanism of action consists, first of all, in a direct stimulation of the arteriolar smooth muscle cells (acidosis) and a sympathetic-mimetic action with a consequent increase in the flow rate and opening of the blocking devices at the level of the capillaries, and secondly in a reduction of the affinity of hemoglobin for O2 with increased tissue oxygenation and lipolysis.

 

  • For this reason, in the forms of so-called cellulitis in which stasis microangiopathy prevails, the subcutaneous administration of CO2 represents a therapy of choice: compactness and elasticity of the skin visibly improves (also demonstrated by elastometric investigation), reduction of skin thickness and superficial depressions (dimpling).
  • The biopsies of patients subjected to CO2 infiltration in the hypodermis at the level of localised adiposity, permitted a histological analyse of the treated tissues and thus verified: “numerous fractures of the adipocyte cell membranes with the presence of lipid material in the interstitium and absence of alterations of the deep dermal and main vascular structures”. This effect translates into a reduction in centimetres of localised adiposity in the abdomen, hips, thighs, knees, buttocks, etc. … Patients undergo one or two weekly sessions for cycles of 10 – 20 sessions and the results are visible from the first sessions.
  • The occasional observation of an increase in elasticity and tone of the skin of the lower limbs, proven by elastometry and histological examination, led us to use carboxytherapy in different body regions, characterised by signs of skin aging: face, neck, décolleté, arms, etc…. The increase in dermal thickness and therefore the fibroblastic stimulation induced by carbon dioxide, explains the fact that the treatment of so-called stretch marks and areas of skin laxity such as the sub-chin region, jaw profile, neck, décolleté, breasts, arms, abdomen, inner thighs and even the eyelids (which until now have been considered a region to be treated only surgically) represent a main indication in the use of this therapy, with results often visible within the first 3-4 treatment sessions.
CONTATTI

Telefono: +39 070 548 8084

Email: info@clinicabestwell.it

Indirizzo: Via Nuoro 10, Cagliari (09125)

RICERCA
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
CONTATTI

Telefono: +39 070 548 8084

Email: info@clinicabestwell.it

Indirizzo: Via Nuoro 10, Cagliari (09125)

RICERCA
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors